Cargando…

Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients

Human cytomegalovirus (CMV) is a major pathogen after solid organ transplantation, leading to high morbidity and mortality. Transplantation from a CMV-seropositive donor to a CMV-seronegative recipient (D+/R−) is associated with high risk of CMV disease. However, that risk is not uniform, suggesting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shapira, Guy, Volkov, Hadas, Fabian, Itai, Mohr, David W., Bettinotti, Maria, Shomron, Noam, Avery, Robin K., Arav-Boger, Ravit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674338/ https://www.ncbi.nlm.nih.gov/pubmed/38005904 http://dx.doi.org/10.3390/v15112227

Ejemplares similares

Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention
por: Pass, Robert F., et al.
Publicado: (2018)

The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients
por: Buyck, Hubertus C, et al.
Publicado: (2009)

2104. Cytomegalovirus DNAemia Patterns in Mismatched Solid Organ Transplant Recipients: A Retrospective Cohort Study.
por: Garcia, Oscar A Fernandez, et al.
Publicado: (2022)

Human Cytomegalovirus Inhibits the PARsylation Activity of Tankyrase—A Potential Strategy for Suppression of the Wnt Pathway
por: Roy, Sujayita, et al.
Publicado: (2015)

1750. Epidemiology of Cytomegalovirus DNAemia in Pediatric Solid-Organ Transplant Patients
por: Valencia Deray, Kristen, et al.
Publicado: (2019)

Activation of Nucleotide Oligomerization Domain 2 (NOD2) by Human Cytomegalovirus Initiates Innate Immune Responses and Restricts Virus Replication
por: Kapoor, Arun, et al.
Publicado: (2014)

Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway
por: Kapoor, Arun, et al.
Publicado: (2016)

Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation
por: Immohr, Moritz Benjamin, et al.
Publicado: (2023)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Diop, Ndeye Soukeyna, et al.
Publicado: (2021)

Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients
por: Ahn, Richard, et al.
Publicado: (2021)

An Artemisinin-Derived Dimer Has Highly Potent Anti-Cytomegalovirus (CMV) and Anti-Cancer Activities
por: He, Ran, et al.
Publicado: (2011)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
por: Baldanti, Fausto, et al.
Publicado: (2011)

Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
por: Chang, Yeh-Chung, et al.
Publicado: (2022)

The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides
por: Guo, Xin, et al.
Publicado: (2022)

934. Epidemiology and Outcomes of Epstein-Barr Virus DNAemia in Adult Solid Organ Transplant Recipients
por: Dong, Sara W, et al.
Publicado: (2021)

Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
por: He, Ran, et al.
Publicado: (2011)

Prevalence, Magnitude, and Genotype Distribution of Urinary Cytomegalovirus (CMV) Shedding Among CMV-Seropositive Children and Adolescents in the United States
por: White, Jodie L, et al.
Publicado: (2019)

Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women
por: Murthy, Suchetha, et al.
Publicado: (2011)

Plasma proteome perturbation for CMV DNAemia in kidney transplantation
por: Sigdel, Tara K., et al.
Publicado: (2023)

The Use of Artificial Neural Networks in Prediction of Congenital CMV Outcome from Sequence Data
por: Arav-Boger, Ravit, et al.
Publicado: (2008)

Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine
por: Arav-Boger, Ravit, et al.
Publicado: (2012)

Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control
por: Ghosh, Ayan K., et al.
Publicado: (2023)

Artemisinin-Derived Dimers Have Greatly Improved Anti-Cytomegalovirus Activity Compared to Artemisinin Monomers
por: Arav-Boger, Ravit, et al.
Publicado: (2010)

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
por: Srinivasan, Krithia, et al.
Publicado: (2022)

Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia
por: Saláková, Martina, et al.
Publicado: (2022)

Cytomegalovirus infection in transplant recipients
por: Azevedo*, Luiz Sergio, et al.
Publicado: (2015)

Unexpectedly High Prevalence of Cytomegalovirus DNAemia in Older Children and Adolescents With Perinatally Acquired Human Immunodeficiency Virus Infection
por: Yindom, Louis-Marie, et al.
Publicado: (2019)

Characterization of Cytomegalovirus Disease in Solid Organ Transplant Recipients by Markers of Inflammation in Plasma
por: Rollag, Halvor, et al.
Publicado: (2013)

Cytomegalovirus Viremia in Renal Transplant Recipients After Influenza Vaccination
por: Khatri, Akshay M, et al.
Publicado: (2020)

1544. Kinetics of BK Virus in Urine Associated with BKV DNAemia and BKVAN in Pediatric Kidney Transplantation
por: Yamada, Masaki, et al.
Publicado: (2018)

Transient Parvovirus B19 DNAemia After Kidney Transplantation: A 2-Sided Story
por: Russcher, Anne, et al.
Publicado: (2023)

Holoendemic cytomegalovirus infection in renal transplant recipients.
por: Fiala, M., et al.
Publicado: (1976)

Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus
por: Mukhopadhyay, Rupkatha, et al.
Publicado: (2016)

Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance
por: Acquier, M, et al.
Publicado: (2023)

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
por: El Helou, Guy, et al.
Publicado: (2019)

686. Elevations in TNFα and IL-18 are Associated with Increased Risk of Probable Cytomegalovirus Tissue Invasive Disease in Solid Organ Transplant Recipients
por: Karaba, Andrew H, et al.
Publicado: (2020)

1588. Epidemiology of Chronic High Level (CHL) Epstein-Barr virus (EBV) DNAemia in Pediatric Solid Organ Transplant Recipients (SOTR) at Texas Children’s Hospital (TCH)
por: Valencia Deray, Kristen G, et al.
Publicado: (2022)

Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants
por: Musialik, Joanna, et al.
Publicado: (2022)

Bacterial DNAemia is associated with serum zonulin levels in older subjects
por: Gargari, Giorgio, et al.
Publicado: (2021)

Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients
por: Avnat, Eden, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3r7kisvt38mkvjdpviqe5j70gj